Free Trial

Harvest Investment Services LLC Buys Shares of 9,635 Scholar Rock Holding Co. (NASDAQ:SRRK)

Scholar Rock logo with Medical background

Harvest Investment Services LLC acquired a new stake in shares of Scholar Rock Holding Co. (NASDAQ:SRRK - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 9,635 shares of the company's stock, valued at approximately $416,000.

Several other hedge funds and other institutional investors have also bought and sold shares of SRRK. Hsbc Holdings PLC purchased a new position in Scholar Rock in the fourth quarter worth $571,000. Rock Springs Capital Management LP acquired a new position in Scholar Rock in the fourth quarter valued at approximately $30,979,000. Teachers Retirement System of The State of Kentucky purchased a new stake in Scholar Rock during the fourth quarter worth $1,038,000. MetLife Investment Management LLC boosted its stake in shares of Scholar Rock by 16.8% during the 4th quarter. MetLife Investment Management LLC now owns 46,667 shares of the company's stock worth $2,017,000 after acquiring an additional 6,701 shares in the last quarter. Finally, Capital World Investors acquired a new stake in Scholar Rock in the fourth quarter valued at approximately $31,203,000. Institutional investors own 91.08% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wedbush reissued an "outperform" rating and set a $50.00 target price on shares of Scholar Rock in a research note on Tuesday, March 25th. Six analysts have rated the stock with a buy rating, According to MarketBeat.com, Scholar Rock currently has an average rating of "Buy" and an average target price of $42.67.

Check Out Our Latest Stock Report on Scholar Rock

Scholar Rock Stock Performance

Shares of Scholar Rock stock opened at $31.64 on Wednesday. The business's 50 day moving average price is $32.99 and its 200 day moving average price is $35.60. The company has a debt-to-equity ratio of 0.63, a quick ratio of 3.88 and a current ratio of 3.88. The company has a market cap of $3.00 billion, a price-to-earnings ratio of -13.46 and a beta of 0.56. Scholar Rock Holding Co. has a one year low of $6.76 and a one year high of $46.98.

Insiders Place Their Bets

In related news, insider Tracey Sacco sold 6,500 shares of the stock in a transaction that occurred on Monday, March 24th. The shares were sold at an average price of $33.08, for a total transaction of $215,020.00. Following the completion of the transaction, the insider now owns 71,750 shares of the company's stock, valued at approximately $2,373,490. This trade represents a 8.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Mo Qatanani sold 68,510 shares of Scholar Rock stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $37.40, for a total value of $2,562,274.00. Following the completion of the sale, the insider now directly owns 111,084 shares of the company's stock, valued at $4,154,541.60. The trade was a 38.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 250,231 shares of company stock valued at $9,056,086 over the last ninety days. Company insiders own 19.20% of the company's stock.

Scholar Rock Profile

(Free Report)

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.

See Also

Want to see what other hedge funds are holding SRRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Scholar Rock Holding Co. (NASDAQ:SRRK - Free Report).

Institutional Ownership by Quarter for Scholar Rock (NASDAQ:SRRK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Scholar Rock Right Now?

Before you consider Scholar Rock, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Scholar Rock wasn't on the list.

While Scholar Rock currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines